Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

68Ga-labeled inhibitors of prostate-specific membrane antigen (PSMA) for imaging prostate cancer.

Banerjee SR, Pullambhatla M, Byun Y, Nimmagadda S, Green G, Fox JJ, Horti A, Mease RC, Pomper MG.

J Med Chem. 2010 Jul 22;53(14):5333-41. doi: 10.1021/jm100623e.

2.

Gallium-68 Prostate-Specific Membrane Antigen PET Imaging.

Hofman MS, Iravani A.

PET Clin. 2017 Apr;12(2):219-234. doi: 10.1016/j.cpet.2016.12.004. Review.

PMID:
28267455
3.

Prostate-specific membrane antigen-based imaging.

Osborne JR, Akhtar NH, Vallabhajosula S, Anand A, Deh K, Tagawa ST.

Urol Oncol. 2013 Feb;31(2):144-54. doi: 10.1016/j.urolonc.2012.04.016. Review.

4.

68Ga-Labeled 2-{3-[5-(7-{1-benzyloxycarbonyl-5-[2-(4,7,10-tris-carboxymethyl-1,4,7,10-tetraazacyclododec-1-l)acetylamino]pentylcarbamoyl}-heptanoylamino)-1-carboxypentyl]ureido}pentanedioic acid.

Chopra A.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2010 Sep 28 [updated 2010 Dec 28].

5.

68Ga-Labeled 2-[3-(1-carboxy-5-{7-[5-carboxy-5-(3-phenyl-2-{3-phenyl-2-[2-(4,7,10-tris-carboxymethyl-1,4,7,10-tetraazacyclododec-1-l)acetylamino]propionylamino}propionylamino)pentylcarbamoyl]heptanoylamino}pentyl)ureido]pentanedioic acid.

Chopra A.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2010 Sep 27 [updated 2010 Dec 28].

6.

Prostate-specific membrane antigen positron emission tomography in prostate cancer: a step toward personalized medicine.

Bouchelouche K, Choyke PL.

Curr Opin Oncol. 2016 May;28(3):216-21. doi: 10.1097/CCO.0000000000000277. Review.

PMID:
26967720
7.

Phosphinic acid functionalized polyazacycloalkane chelators for radiodiagnostics and radiotherapeutics: unique characteristics and applications.

Notni J, Šimeček J, Wester HJ.

ChemMedChem. 2014 Jun;9(6):1107-15. doi: 10.1002/cmdc.201400055. Review. Erratum in: ChemMedChem. 2014 Dec;9(12):2614.

PMID:
24700633
8.

Prostate-specific membrane antigen as a target for cancer imaging and therapy.

Kiess AP, Banerjee SR, Mease RC, Rowe SP, Rao A, Foss CA, Chen Y, Yang X, Cho SY, Nimmagadda S, Pomper MG.

Q J Nucl Med Mol Imaging. 2015 Sep;59(3):241-68. Review.

9.

Gallium-68: chemistry and radiolabeled peptides exploring different oncogenic pathways.

Morgat C, Hindié E, Mishra AK, Allard M, Fernandez P.

Cancer Biother Radiopharm. 2013 Mar;28(2):85-97. doi: 10.1089/cbr.2012.1244. Review.

PMID:
23461410

Supplemental Content

Support Center